Assessment and characteristics of Erenumab therapy on migraine management

BACKGROUND: Migraine is one of the neurological diseases that have a negative impact on subjects’ productivity and daily activity of patients. Introducing monoclonal antibodies as a valuable option for resolving the persistent problem of migraine is still under investigation. The current study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Haitham, Tulbah, Alaa S., Gamal, Amr, Kamal, Marwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508638/
https://www.ncbi.nlm.nih.gov/pubmed/36164568
http://dx.doi.org/10.1016/j.jsps.2022.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508638/
https://www.ncbi.nlm.nih.gov/pubmed/36164568
http://dx.doi.org/10.1016/j.jsps.2022.06.015

Ejemplares similares